{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:03:30Z","timestamp":1779753810384,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funded by Science and Technology Project of Hebei Education Department","award":["(BJK2024152)"],"award-info":[{"award-number":["(BJK2024152)"]}]},{"name":"Hebei Province Medical Science Research Project Plan for 2024","award":["(20241988)"],"award-info":[{"award-number":["(20241988)"]}]},{"name":"Project Fund of Clinical Medicine Excellent Talents funded by Hebei Provincial Department of Finance","award":["(No. [2020] No.23)."],"award-info":[{"award-number":["(No. [2020] No.23)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94359-6","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:36:13Z","timestamp":1774672573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Lactobacillus johnsonii on glycemic control and lipid metabolism in type 2 diabetes with circadian disruption"],"prefix":"10.1038","volume":"16","author":[{"given":"Yang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Hongxia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhenhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xianghui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Defeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"94359_CR1","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus [J]. Int. J. Mol. Sci., 21(17). (2020).","DOI":"10.3390\/ijms21176275"},{"key":"94359_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 [J]. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"94359_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications [J]. Physiol. Rev. 93 (1), 137\u2013188 (2013).","journal-title":"Physiol. Rev."},{"issue":"11","key":"94359_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S2213-8587(18)30052-4","volume":"6","author":"AL Gloyn","year":"2018","unstructured":"Gloyn, A. L. & Drucker, D. J. Precision medicine in the management of type 2 diabetes [J]. Lancet Diabetes Endocrinol. 6 (11), 891\u2013900 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"94359_CR5","unstructured":"Perez, J. F. et al. Shift and night work management in European companies [J]. 20(169):157\u2013165. (2019)."},{"key":"94359_CR6","doi-asserted-by":"crossref","unstructured":"Shan, Z. et al. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses [J]. BMJ, 363k4641. (2018).","DOI":"10.1136\/bmj.k4641"},{"issue":"4","key":"94359_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2337\/dc17-1933","volume":"41","author":"C Vetter","year":"2018","unstructured":"Vetter, C. et al. Night shift work, genetic risk, and type 2 diabetes in the UK biobank [J]. Diabetes Care. 41 (4), 762\u2013769 (2018).","journal-title":"Diabetes Care"},{"issue":"12","key":"94359_CR8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00592-021-01770-2","volume":"58","author":"Y Osaki","year":"2021","unstructured":"Osaki, Y. et al. Shift work and the onset of type 2 diabetes: results from a large-scale cohort among Japanese workers [J]. Acta Diabetol. 58 (12), 1659\u20131664 (2021).","journal-title":"Acta Diabetol."},{"issue":"49","key":"94359_CR9","doi-asserted-by":"publisher","first-page":"eabg9910","DOI":"10.1126\/sciadv.abg9910","volume":"7","author":"SL Chellappa","year":"2021","unstructured":"Chellappa, S. L. et al. Daytime eating prevents internal circadian misalignment and glucose intolerance in night work [J]. Sci. Adv. 7 (49), eabg9910 (2021).","journal-title":"Sci. Adv."},{"issue":"2","key":"94359_CR10","first-page":"138","volume":"33","author":"N Javeed","year":"2018","unstructured":"Javeed, N. & Matveyenko, A. V. Circadian etiology of type 2 diabetes mellitus [J]. Physiol. (Bethesda). 33 (2), 138\u2013150 (2018).","journal-title":"Physiol. (Bethesda)"},{"key":"94359_CR11","doi-asserted-by":"crossref","unstructured":"Wang, R. et al. Gut microbiome, liver immunology, and liver diseases [J]. Cell. Mol. Immunol., 18(1). (2021).","DOI":"10.1038\/s41423-020-00592-6"},{"issue":"7430","key":"94359_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature11711","volume":"493","author":"S Schloissnig","year":"2013","unstructured":"Schloissnig, S. et al. Genomic variation landscape of the human gut Microbiome [J]. Nature 493 (7430), 45\u201350 (2013).","journal-title":"Nature"},{"key":"94359_CR13","doi-asserted-by":"crossref","unstructured":"Wu, H. et al. The gut microbiota in prediabetes and diabetes: A Population-Based Cross-Sectional study [J]. Cell. Metab., 32(3). (2020).","DOI":"10.1016\/j.cmet.2020.06.011"},{"issue":"2","key":"94359_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/dc20-1536","volume":"44","author":"W Gou","year":"2021","unstructured":"Gou, W. et al. Interpretable machine learning framework reveals robust gut Microbiome features associated with type 2 diabetes [J]. Diabetes Care. 44 (2), 358\u2013366 (2021).","journal-title":"Diabetes Care"},{"key":"94359_CR15","doi-asserted-by":"crossref","unstructured":"Reitmeier, S. et al. Arrhythmic gut Microbiome signatures predict risk of type 2 diabetes [J]. Cell. Host Microbe, 28(2). (2020).","DOI":"10.1016\/j.chom.2020.06.004"},{"key":"94359_CR16","doi-asserted-by":"crossref","unstructured":"Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology [J]. EBioMedicine, 51(102590). (2020).","DOI":"10.1016\/j.ebiom.2019.11.051"},{"issue":"1","key":"94359_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13099-021-00446-0","volume":"13","author":"AL Cunningham","year":"2021","unstructured":"Cunningham, A. L. & Stephens JW,Harris, D. A. Gut microbiota influence in type 2 diabetes mellitus (T2DM) [J]. Gut Pathog. 13 (1), 50 (2021).","journal-title":"Gut Pathog"},{"issue":"6","key":"94359_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/jsr.12554","volume":"26","author":"A Manodpitipong","year":"2017","unstructured":"Manodpitipong, A. et al. Night-shift work is associated with poorer glycaemic control in patients with type 2 diabetes [J]. J. Sleep. Res. 26 (6), 764\u2013772 (2017).","journal-title":"J. Sleep. Res."},{"issue":"12","key":"94359_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.15537\/smj.2021.42.12.20210416","volume":"42","author":"MA Albishri","year":"2021","unstructured":"Albishri, M. A. et al. Association between glycemic control and shift working among healthcare workers with diabetes, Dammam, Saudi Arabia: five years\u2019 experience [J]. Saudi Med. J. 42 (12), 1296\u20131301 (2021).","journal-title":"Saudi Med. J."},{"issue":"10","key":"94359_CR20","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/dom.13391","volume":"20","author":"J Qian","year":"2018","unstructured":"Qian, J. et al. Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans [J]. Diabetes Obes. Metab. 20 (10), 2481\u20132485 (2018).","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"94359_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/07420528.2020.1778717","volume":"37","author":"H Morta\u015f","year":"2020","unstructured":"Morta\u015f, H., Bilici, S. & Karakan, T. The circadian disruption of night work alters gut microbiota consistent with elevated risk for future metabolic and Gastrointestinal pathology [J]. Chronobiol Int. 37 (7), 1067\u20131081 (2020).","journal-title":"Chronobiol Int."},{"issue":"3","key":"94359_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cell.2014.09.048","volume":"159","author":"CA Thaiss","year":"2014","unstructured":"Thaiss, C. A. et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis [J]. Cell 159 (3), 514\u2013529 (2014).","journal-title":"Cell"},{"issue":"12","key":"94359_CR23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.molmet.2016.10.003","volume":"5","author":"C Benedict","year":"2016","unstructured":"Benedict, C. et al. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals [J]. Mol. Metab. 5 (12), 1175\u20131186 (2016).","journal-title":"Mol. Metab."},{"issue":"1","key":"94359_CR24","doi-asserted-by":"publisher","first-page":"2005407","DOI":"10.1080\/19490976.2021.2005407","volume":"14","author":"S Wei","year":"2022","unstructured":"Wei, S. et al. Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a analysis of a randomized clinical trial [J]. Gut Microbes. 14 (1), 2005407 (2022).","journal-title":"Gut Microbes"},{"issue":"7728","key":"94359_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-018-0620-2","volume":"562","author":"T Vatanen","year":"2018","unstructured":"Vatanen, T. et al. The human gut Microbiome in early-onset type 1 diabetes from the TEDDY study [J]. Nature 562 (7728), 589\u2013594 (2018).","journal-title":"Nature"},{"issue":"5","key":"94359_CR26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.chest.2016.12.007","volume":"151","author":"EM Wickwire","year":"2017","unstructured":"Wickwire, E. M. et al. Shift work and shift work sleep disorder: clinical and organizational perspectives [J]. Chest 151 (5), 1156\u20131172 (2017).","journal-title":"Chest"},{"issue":"1","key":"94359_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes [J]. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"94359_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms [J]. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"94359_CR29","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes [J]. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"94359_CR30","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM De Vos","year":"2022","unstructured":"De Vos, W. M. et al. Gut Microbiome and health: mechanistic insights [J]. Gut 71 (5), 1020\u20131032 (2022).","journal-title":"Gut"},{"issue":"16","key":"94359_CR31","doi-asserted-by":"publisher","first-page":"e2100536","DOI":"10.1002\/advs.202100536","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes [J]. Adv. Sci. (Weinh). 8 (16), e2100536 (2021).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"94359_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng, S. C. et al. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial [J]. Gut 71 (4), 716\u2013723 (2022).","journal-title":"Gut"},{"issue":"5","key":"94359_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","volume":"9","author":"F Zhang","year":"2018","unstructured":"Zhang, F. et al. Microbiota transplantation: concept, methodology and strategy for its modernization [J]. Protein Cell. 9 (5), 462\u2013473 (2018).","journal-title":"Protein Cell."},{"key":"94359_CR34","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired Islets [J]. Front. Cell. Infect. Microbiol., 9(455). (2019).","DOI":"10.3389\/fcimb.2019.00455"},{"key":"94359_CR35","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice [J]. Arch. Physiol. Biochem., 1\u20139. (2022).","DOI":"10.1080\/13813455.2022.2080229"},{"key":"94359_CR36","doi-asserted-by":"crossref","unstructured":"Bastos, R. M. C. et al. Fecal microbiota transplant in a Pre-Clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease [J]. Int. J. Mol. Sci., 23(7). (2022).","DOI":"10.3390\/ijms23073842"},{"issue":"16","key":"94359_CR37","first-page":"1224","volume":"102","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Li, Y. Y. & Liu, Y. [Effect of fecal microbiota transplantation on type 1 diabetes mellitus in non-obese diabetic mice and its underlying mechanism] [J]. Zhonghua Yi Xue Za Zhi. 102 (16), 1224\u20131231 (2022).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"94359_CR38","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1038\/s41467-022-32015-7","volume":"13","author":"K Hosomi","year":"2022","unstructured":"Hosomi, K. et al. Oral administration of blautia Wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota [J]. Nat. Commun. 13 (1), 4477 (2022).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94359-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:25:16Z","timestamp":1779751516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["94359"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94359-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4883748\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Committee of Hebei University of Engineering affiliated hospital. The patients\/participants provided their written informed consent to participate in this study.This animal experiments was approved by the Institutional Animal Care and Use Committee of Hebei University of Engineering affiliated hospital (IACUC-Hebeu-2023-0006).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"16220"}}